MedTrace Logo

Yoga and Vibration Training for Stress Urinary Incontinence in Women

NCT06705283 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-11-26

No results posted yet for this study

Summary

This study aimed to compare the effects of yoga and Whole Body Vibration Training on pelvic floor muscle strength, severity of urinary symptoms and UI-related quality of life in women with UI.

The intervention period for the study was determined as 6 weeks. It has been decided that yoga practice will be done 3 times a week for 45 minutes, and whole body vibration training will be done for 45-55 minutes. The home exercise group will perform the planned exercise protocol every day for 6 weeks.

The results of the study will be evaluated by statistical analysis as a result of the interventions and evaluations.

Conditions

Interventions

PROCEDURE

yoga and home exercise

The intervention period for the study was determined as 6 weeks. It has been decided that yoga practice will be done 3 times a week for 45 minutes. Poses to be practiced in the yoga group: 1. Tadasana (mountain pose) 2. Utkatasana (chair pose) 3. Trikonasana (triangle pose) 4. Malasana (squat pose): 5. Viparita Karani Variation (legs up the wall pose) 6. Salamba Set Bandhasana (supported bridge pose) 7. Supta Baddha Konasana (reclining bound angle pose) 8. Savasana (dead pose)

PROCEDURE

whole body vibration training and home exercise

A total of 40-45 minutes of training was planned for WBVT, including warm-up (10 minutes), active phase (25-30 minutes) and cooling phase (5 minutes).

PROCEDURE

home exercise group

Pelvic floor muscle training will be done in the home exercise group. This training will be done in the form of slow and fast contractions of the pelvic floor muscles in supine, chin up, sitting, squat and standing positions.

Sponsors & Collaborators

  • Suleyman Demirel University

    lead OTHER

Principal Investigators

  • Zeliha Baskurt, Prof · Suleyman Demirel University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-11-30
Completion
2026-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06705283 on ClinicalTrials.gov